Bill Information > HB 2710
Search for another bill or initiative:
HB 2710 - 2019-20
Modifying the uses, disclosure, and requirement dates of prescription drug price transparency data.
2020 REGULAR SESSION
First reading, referred to Health Care & Wellness. (View Original Bill)
Public hearing in the House Committee on Health Care & Wellness at 1:30 PM. (Committee Materials)
Executive action taken in the House Committee on Health Care & Wellness at 1:30 PM. (Committee Materials)
HCW - Majority; do pass. (Majority Report)
Referred to Rules 2 Review.
Rules Committee relieved of further consideration. Placed on second reading.
Rules suspended. Placed on Third Reading.
Third reading, passed; yeas, 56; nays, 42; absent, 0; excused, 0. (View Roll Calls)
IN THE SENATE
First reading, referred to Health & Long Term Care.
Public hearing and executive session scheduled, but no action was taken in the Senate Committee on Health & Long Term Care at 8:00 AM. (Committee Materials)
By resolution, returned to House Rules Committee for third reading.
For a complete list of documents, go to Online Reports Text of a Legislative Document.